Federal Court dismisses action alleging patent infringement by new Apotex heartburn drug
The Federal Court has dismissed claims that a new Apotex drug infringes a patent, finding the asserted claims as invalid and not infringed by the new drug....To view the full article, register now.
Already a subscriber? Click here to view full article